HCA Healthcare, Inc. to Post Q1 2021 Earnings of $3.20 Per Share, William Blair Forecasts (NYSE:HCA)

HCA Healthcare, Inc. (NYSE:HCA) – Stock analysts at William Blair decreased their Q1 2021 earnings estimates for HCA Healthcare in a research report issued to clients and investors on Monday, October 26th. William Blair analyst M. Larew now anticipates that the company will earn $3.20 per share for the quarter, down from their prior estimate of $3.63. William Blair also issued estimates for HCA Healthcare’s Q4 2021 earnings at $3.16 EPS.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Monday, October 26th. The company reported $1.92 EPS for the quarter, missing the consensus estimate of $2.69 by ($0.77). The company had revenue of $13.31 billion for the quarter, compared to the consensus estimate of $12.92 billion. HCA Healthcare had a negative return on equity of 589.47% and a net margin of 6.67%. The business’s quarterly revenue was up 4.9% on a year-over-year basis. During the same period in the previous year, the firm posted $2.23 EPS.

Other analysts have also recently issued research reports about the stock. Citigroup lifted their price objective on shares of HCA Healthcare from $131.00 to $142.00 and gave the stock a “buy” rating in a research note on Thursday, July 23rd. Truist lifted their price objective on shares of HCA Healthcare from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Wednesday, September 16th. Barclays lifted their price objective on shares of HCA Healthcare from $140.00 to $150.00 and gave the stock an “overweight” rating in a research note on Tuesday. Oppenheimer boosted their target price on shares of HCA Healthcare from $135.00 to $140.00 in a research report on Thursday, July 23rd. Finally, ValuEngine upgraded shares of HCA Healthcare from a “sell” rating to a “hold” rating in a research report on Tuesday. Five analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $152.10.

Shares of HCA Healthcare stock opened at $123.94 on Thursday. HCA Healthcare has a twelve month low of $58.38 and a twelve month high of $151.97. The company has a quick ratio of 0.95, a current ratio of 1.09 and a debt-to-equity ratio of 54.19. The company has a 50-day simple moving average of $130.50 and a two-hundred day simple moving average of $117.55. The stock has a market capitalization of $41.90 billion, a price-to-earnings ratio of 12.78, a price-to-earnings-growth ratio of 1.20 and a beta of 1.39.

The company also recently announced a monthly dividend, which will be paid on Thursday, November 12th. Stockholders of record on Friday, October 30th will be issued a $0.072 dividend. The ex-dividend date of this dividend is Thursday, October 29th. This represents a $0.86 annualized dividend and a dividend yield of 0.70%.

In other news, SVP P. Martin Paslick sold 254 shares of the stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $132.97, for a total value of $33,774.38. Following the sale, the senior vice president now directly owns 5,442 shares of the company’s stock, valued at $723,622.74. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider A Bruce Moore, Jr. sold 15,000 shares of the stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $133.73, for a total transaction of $2,005,950.00. Following the completion of the sale, the insider now directly owns 88,626 shares in the company, valued at $11,851,954.98. The disclosure for this sale can be found here. Insiders have sold 16,331 shares of company stock valued at $2,183,838 in the last quarter. Company insiders own 1.80% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Sanders Capital LLC purchased a new position in shares of HCA Healthcare during the second quarter worth approximately $723,683,000. First Eagle Investment Management LLC grew its holdings in shares of HCA Healthcare by 0.6% in the second quarter. First Eagle Investment Management LLC now owns 2,372,183 shares of the company’s stock worth $230,244,000 after purchasing an additional 13,352 shares during the last quarter. FIL Ltd grew its holdings in shares of HCA Healthcare by 47.5% in the second quarter. FIL Ltd now owns 2,163,384 shares of the company’s stock worth $209,978,000 after purchasing an additional 696,740 shares during the last quarter. FMR LLC grew its holdings in shares of HCA Healthcare by 42.3% in the second quarter. FMR LLC now owns 2,148,926 shares of the company’s stock worth $208,575,000 after purchasing an additional 638,628 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in shares of HCA Healthcare by 0.5% in the second quarter. Bank of New York Mellon Corp now owns 1,998,084 shares of the company’s stock worth $193,935,000 after purchasing an additional 10,415 shares during the last quarter. 68.28% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Recommended Story: Example of operating income, EBIT and EBITDA

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.